These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10427129)

  • 1. Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agents.
    Crenshaw TR; Cory JG
    Int J Oncol; 1999 Sep; 15(3):487-90. PubMed ID: 10427129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory AH; Sato A; Thompson DP; Cory JG
    Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered efflux properties of mouse leukemia L1210 cells resistant to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
    Cory JG; Cory AH; Lorico A; Rappa G; Sartorelli AC
    Anticancer Res; 1997; 17(5A):3185-93. PubMed ID: 9413147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase.
    Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC
    Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
    Somerville L; Cory JG
    Anticancer Res; 2000; 20(5B):3347-55. PubMed ID: 11131634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
    Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
    Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase.
    Williams MT; Simonet L; Cory AH; Cory JG
    Cancer Res; 1988 Nov; 48(22):6375-8. PubMed ID: 3052801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.
    Somerville L; Cory JG
    Anticancer Res; 1999; 19(2A):1021-6. PubMed ID: 10368649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase.
    Carter GL; Cory JG
    Adv Enzyme Regul; 1989; 29():123-39. PubMed ID: 2699151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells.
    He AW; Cory JG
    Int J Oncol; 1999 May; 14(5):891-5. PubMed ID: 10200338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between sensitivity to hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIO) and ribonucleotide reductase RNR2 mRNA levels in strains of Saccharomyces cerevisiae.
    Rittberg DA; Wright JA
    Biochem Cell Biol; 1989 Jul; 67(7):352-7. PubMed ID: 2675933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells.
    Hall JG; Cory AH; Hickerson DH; Cory JG
    Anticancer Res; 2001; 21(1A):173-80. PubMed ID: 11299731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia.
    Fritzer-Szekeres M; Novotny L; Romanova D; Göbl R; Sedlak J; Vachalkova A; Rauko P; Elford HL; Szekeres T
    Life Sci; 1998; 63(7):545-52. PubMed ID: 9718080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
    Cory AH; Cory JG
    Biochem Biophys Res Commun; 1998 Aug; 249(3):687-91. PubMed ID: 9731198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression.
    Cory AH; Hickerson DH; Cory JG
    Anticancer Res; 2000; 20(6B):4171-8. PubMed ID: 11205244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
    Cory AH; Cory JG
    Anticancer Res; 2001; 21(6A):3807-11. PubMed ID: 11911251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.